Critical Analysis of the Updated Barcelona Clinic Liver Cancer (BCLC) Group Guidelines Diamantis I. TsilimigrasHassan AzizTimothy M. Pawlik ASO Perspectives 19 July 2022 Pages: 7231 - 7234
Bridging the Disparity Gap in Surgical Oncology Access: Does Telehealth Hold a Key? Elliot A. AsareMichael H. AndreaeJohn H. Stewart IV Global Health Services Research 19 July 2022 Pages: 7235 - 7236
Assessment of the PARITY Sub-Analysis “Neoadjuvant Chemotherapy and Endoprosthetic Reconstruction for Lower Extremity Sarcomas: Does Timing Impact Complication Rates?” Lauren ZeitlingerR. Lor Randall Sarcoma 30 July 2022 Pages: 7237 - 7238
Patient-Derived Sarcoma Organoids Offer a Novel Platform for Personalized Precision Medicine Adrian Sanchez-FdezAshwyn K. SharmaJason K. Sicklick Translational Research 13 July 2022 Pages: 7239 - 7241
Optimizing Sarcopenia to Strengthen Patient Outcomes After Lung and Esophageal Surgery Sadia TasnimMonisha Sudarshan Thoracic Oncology 30 July 2022 Pages: 7242 - 7243
Don’t Call It a Comeback—HIPEC for Gastric Cancer Brian D. Badgwell Peritoneal Surface Malignancy 08 August 2022 Pages: 7244 - 7245
Genomic Predictors of Recurrence Patterns After Complete Resection of Colorectal Liver Metastases and Adjuvant Hepatic Artery Infusion Chemotherapy by Narayan et al. Sean J. JudgeMay ChoSepideh Gholami Hepatobiliary Tumors 12 July 2022 Pages: 7246 - 7247
Overcoming Treatment Disparities for Early-Stage Hepatocellular Carcinoma in the Veteran Population: Is the MISSION Act the Solution? Robin SchmitzMichael E. Lidsky Hepatobiliary Tumors 15 September 2022 Pages: 7248 - 7249
Utilization of National Cancer Institute-Designated Cancer Centers by Medicare Beneficiaries with Cancer Parsa ErfaniAyotomiwa OjoMiranda B. Lam ASO Research Letter 02 July 2022 Pages: 7250 - 7258
‘At All Costs’: Breast Cancer Patient Responses to Cost Transparency and Communication Lily A. GutnikLaura J. FishRachel A. Greenup ASO Research Letter 09 July 2022 Pages: 7259 - 7260
Contemporary Analysis of Sentinel Lymph Node Biopsy Performance Among Patients with Clinically Localized Merkel Cell Carcinoma Richard J. Straker IIICimarron E. SharonJohn T. Miura ASO Research Letter 11 July 2022 Pages: 7261 - 7264
Avoiding Axillary Management Pitfalls After Neoadjuvant Chemotherapy Betty FanTed James ASO Research Letter 16 August 2022 Pages: 7265 - 7266
Telehealth Utilization Among Surgical Oncology Patients at a Large Academic Cancer Center Alessandro ParoDaniel R. RiceTimothy M. Pawlik Global Health Services Research 27 July 2022 Pages: 7267 - 7276
ASO Author Reflections: Improving Telehealth Access and Its Implications in a Post-Pandemic Era Daniel R. RiceTimothy M. Pawlik ASO Author Reflections 18 July 2022 Pages: 7277 - 7278
ASO Visual Abstract: Telehealth Utilization Among Surgical Oncology Patients at a Large Academic Cancer Center Alessandro ParoDaniel R. Rice Timothy M. Pawlik ASO Visual Abstract 27 August 2022 Pages: 7279 - 7280
Use of Palliative Interventions at End of Life for Advanced Gastrointestinal Cancer Vivi W. ChenJorge I. PortuondoNader N. Massarweh Global Health Services Research 10 August 2022 Pages: 7281 - 7292
ASO Author Reflections: Palliative Interventions in Cancer Care Within the Last Year of Life: Unnecessary or Underutilized? Vivi W. ChenNader N. Massarweh ASO Author Reflections 06 August 2022 Pages: 7293 - 7294
ASO Visual Abstract: Use of Palliative Interventions at End of Life for Advanced Gastrointestinal Cancer Vivi W. ChenJorge I. PortuondoNader N. Massarweh ASO Visual Abstract 16 August 2022 Pages: 7295 - 7296
Landmark Series: A Review of Landmark Studies in the Treatment of Primary Localized Retroperitoneal Sarcoma Megan DelisleDavid GyorkiCarolyn Nessim Sarcoma 10 September 2022 Pages: 7297 - 7311
Neoadjuvant Chemotherapy and Endoprosthetic Reconstruction for Lower Extremity Sarcomas: Does Timing Impact Complication Rates? Aaron M. GazendamPatricia SchneiderMichelle Ghert Sarcoma 21 July 2022 Pages: 7312 - 7317
ASO Author Reflections: Timing of Neoadjuvant Chemotherapy in Patients with Sarcoma Aaron M. GazendamMichelle Ghert ASO Author Reflections 26 July 2022 Pages: 7318 - 7318
ASO Visual Abstract: Neoadjuvant Chemotherapy and Endoprosthetic Reconstruction for Lower-Extremity Sarcomas—Does Timing Impact Complication Rates? Aaron M. GazendamPatricia Schneiderthe PARITY Investigators ASO Visual Abstract 16 August 2022 Pages: 7319 - 7319
Association Between Ageing and Short-Term Survival Outcomes in Patients Undergoing Surgery for Primary Retroperitoneal Sarcoma Fabio TirottaMichael G. FadelDirk C. Strauss Sarcoma 19 July 2022 Pages: 7320 - 7330
ASO Author Reflections: Retroperitoneal Sarcoma Surgery in the Elderly Fabio TirottaDirk C. Strauss ASO Author Reflections 18 July 2022 Pages: 7331 - 7332
ASO Visual Abstract: Association Between Ageing and Short-Term Survival Outcomes in Patients Undergoing Surgery for Primary Retroperitoneal Sarcoma Fabio TirottaMichael G. FadelDirk C. Strauss ASO Visual Abstract 29 July 2022 Pages: 7333 - 7334
Management of Locally Recurrent Retroperitoneal Sarcoma in the Adult: An Updated Consensus Approach from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group William W. TsengCarol J. Swallowthe Transatlantic Australasian Retroperitoneal Sarcoma Working Group Sarcoma 29 June 2022 Pages: 7335 - 7348
ASO Author Reflections: Management of Locally Recurrent Retroperitoneal Sarcoma: The Balance is Tipped Towards Biology William W. TsengCarol J. SwallowAlessandro Gronchi ASO Author Reflections 28 June 2022 Pages: 7349 - 7350
Letter to Editor Referring to the Editorial by Istl et al. ‘Good Bone Structure: A Call for Stronger Design and Methodology in Disparity Studies in Orthopedic Oncology’ Discussing the Published Article: ‘Non-Private Health Insurance Predicts Advanced Stage at Presentation and Amputation in Lower-Extremity High-Grade Bone Sarcoma: A National Cancer Database Study’ Muhammad Umar JawadBrad H. PollockSteven W. Thorpe Sarcoma 25 July 2022 Pages: 7351 - 7352
Correction to: ASO Author Reflections: Insurance-Related Disparities in High Grade Bone Sarcoma of Lower Extremity Muhammad Umar JawadBrad H. PollockSteven W. Thorpe Correction 15 April 2022 Pages: 7353 - 7353
Patient-Specific Sarcoma Organoids for Personalized Translational Research: Unification of the Operating Room with Rare Cancer Research and Clinical Implications Steven D. ForsytheHemamylammal SivakumarKonstantinos I. Votanopoulos Translational Research 03 July 2022 Pages: 7354 - 7367
ASO Author Reflections: Sarcoma Organoids: Neutralizing the Word “Rare” in Rare Cancers Steven D. ForsytheHemamylammal SivakumarKonstantinos I. Votanopoulos ASO Author Reflections 01 July 2022 Pages: 7368 - 7369
ASO Visual Abstract: Patient-Specific Sarcoma Organoids for Personalized Translational Research: Unification of the Operating Room with Rare Cancer Research and Clinical Implications Steven D. ForsytheHemamylammal SivakumarKonstantinos I. Votanopoulos ASO Visual Abstract 15 July 2022 Pages: 7370 - 7371
Molecular Basis of Extramural Vascular Invasion (EMVI) in Colorectal Carcinoma Swati SonalVikram DeshpandeDavid L. Berger Translational Research 02 August 2022 Pages: 7372 - 7382
ASO Author Reflections: Colorectal Cancers with Extramural Vascular Invasion Are Associated with a Low Immune Microenvironment Swati SonalDavid L. Berger ASO Author Reflections 05 August 2022 Pages: 7383 - 7383
ASO Visual Abstract: Molecular Basis of Extramural Vascular Invasion (EMVI) in Colorectal Carcinoma Swati SonalVikram DeshpandeDavid L. Berger ASO Visual Abstract 25 August 2022 Pages: 7384 - 7385
Metabolomic Analysis Reveals that SPHK1 Promotes Oral Squamous Cell Carcinoma Progression through NF-κB Activation Chen-xing HouGuang-yan MaoJin-hai Ye Translational Research 12 July 2022 Pages: 7386 - 7399
Changes in the Gustave Roussy Immune Score as a Powerful Prognostic Marker of the Therapeutic Sensitivity of Nivolumab in Advanced Gastric Cancer: A Multicenter, Retrospective Study Nobuhiro NakazawaMakoto SohdaHiroshi Saeki Translational Research 20 July 2022 Pages: 7400 - 7406
ASO Author Reflections: Changes in the Gustave Roussy Immune Score is an Important Biomarker for Therapeutic Sensitivity of Nivolumab in Gastric Cancer Nobuhiro NakazawaAkihiko SanoHiroshi Saeki ASO Author Reflections 16 July 2022 Pages: 7407 - 7408
ASO Visual Abstract: Changes in the Gustave Roussy Immune Score as a Powerful Prognostic Marker of the Therapeutic Sensitivity of Nivolumab in Advanced Gastric Cancer: A Multicenter, Retrospective Study Nobuhiro NakazawaMakoto SohdaHiroshi Saeki ASO Visual Abstract 06 August 2022 Pages: 7409 - 7409
A Translational Randomized Trial of Perioperative Arginine Immunonutrition on Natural Killer Cell Function in Colorectal Cancer Surgery Patients Leonard AngkaAndre B. MartelRebecca C. Auer Translational Research 25 July 2022 Pages: 7410 - 7420
ASO Visual Abstract: A Translational Randomized Trial of Perioperative Arginine Immunonutrition on Natural Killer Cell Function in Colorectal Cancer Surgery Patients Leonard AngkaAndre B. MartelRebecca C. Auer ASO Visual Abstract 01 August 2022 Pages: 7421 - 7422
Immune Evasion of Hepatoma Cancer Stem-Like Cells from Natural Killer Cells Yuta KimuraRyouichi TsunedomiHiroaki Nagano Translational Research 25 July 2022 Pages: 7423 - 7433
ASO Author Reflections: Characteristics of Immune Evasion from Natural Killer Cells in Hepatoma Cancer Stem-Like Cells Yuta KimuraRyouichi TsunedomiHiroaki Nagano ASO Author Reflections 26 August 2022 Pages: 7434 - 7434
PLXND1/SEMA3E Promotes Epithelial–Mesenchymal Transition Partly via the PI3K/AKT-Signaling Pathway and Induces Heterogenity in Colorectal Cancer Kiyotaka HagiharaNaotsugu HaraguchiHidetoshi Eguchi Translational Research 02 August 2022 Pages: 7435 - 7445
ASO Visual Abstract: PLXND1/SEMA3E Promotes EMT Partly via the PI3K/AKT Signaling Pathway and Induces Heterogeneity in Colorectal Cancer Kiyotaka HagiharaNaotsugu HaraguchiHidetoshi Eguchi ASO Visual Abstract 01 August 2022 Pages: 7446 - 7447
Fecal Microbes Associated with the Outcomes After Esophagectomy in Patients with Esophageal Cancer Suguru MaruyamaAkihiko OkamuraMasayuki Watanabe Translational Research 14 July 2022 Pages: 7448 - 7457
ASO Author Reflections: Are Fecal Microbes Associated With Outcomes After Esophageal Cancer Surgery? Suguru MaruyamaAkihiko OkamuraMasayuki Watanabe ASO Author Reflections 11 July 2022 Pages: 7458 - 7459
ASO Visual Abstract: Fecal Microbes Associated with the Outcomes After Esophagectomy in Patients with Esophageal Cancer Suguru MaruyamaAkihiko OkamuraMasayuki Watanabe ASO Visual Abstract 27 July 2022 Pages: 7460 - 7461
Predictive Ability of the Five-time Chair Stand Test for Postoperative Pneumonia after Minimally Invasive Esophagectomy for Esophageal Cancer Daisuke KuritaToru SakuraiHiroyuki Daiko Thoracic Oncology 08 July 2022 Pages: 7462 - 7470
ASO Visual Abstract: Predictive Ability of the Five-Time Chair Stand Test for Postoperative Pneumonia After Minimally Invasive Esophagectomy for Esophageal Cancer Daisuke KuritaToru SakuraiHiroyuki Daiko ASO Visual Abstract 28 July 2022 Pages: 7471 - 7472